Dissertations / Theses on the topic 'Health care reimbursement'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 27 dissertations / theses for your research on the topic 'Health care reimbursement.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Cabrera, Katherine Marie. "Florida's health care reimbursement for outpatient medical nutrition therapy." FIU Digital Commons, 2002. http://digitalcommons.fiu.edu/etd/1957.
Full textTeerawattananon, Yot. "Assessing the feasibility of using economic evaluation in reimbursement of health care services in Thailand." Thesis, University of East Anglia, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.433921.
Full textGopinath, Puja Gopinath. "A Review of Pricing and Reimbursement for Abeona Theraputics’ Gene Therapy Products to Treat Sanfilippo Syndrome." Case Western Reserve University School of Graduate Studies / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=case1497024647261096.
Full textChambers, James D. "Current use and potential value of cost-effectiveness analysis in U.S. health care : the case of Medicare national coverage determinations." Thesis, Brunel University, 2012. http://bura.brunel.ac.uk/handle/2438/6521.
Full textLundkvist, Jonas. "The role of economic evaluations in health care decision making /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-423-6/.
Full textForsberg, Ewa. "Do Financial Incentives Make a Difference? : A Comparative Study of the Effects of Performance-Based Reimbursement in Swedish Health Care." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2001. http://publications.uu.se/theses/91-554-5123-3/.
Full textFowler, Erica N. Fowler. "Development of an Administrative Claims-Based Prospective Risk Tier Method for Percutaneous Coronary Intervention Episodes of Care." The Ohio State University, 2018. http://rave.ohiolink.edu/etdc/view?acc_num=osu1542467861407973.
Full textVacková, Martina. "Finanční aspekty reformy zdravotnictví v ČR." Master's thesis, Vysoká škola ekonomická v Praze, 2011. http://www.nusl.cz/ntk/nusl-85213.
Full textDavidson, Carrie Jane. "Profit Status and the Relationship between Medicaid Reimbursement and Nursing Home Quality in Ohio Nursing Homes." Connect to text online, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1138477611.
Full text[School of Medicine] Department of Epidemiology and Biostatistics. Includes bibliographical references. Available online via OhioLINK's ETD Center.
Krauchunas, Matthew. "EXAMINING CALIFORNIA’S ASSEMBLY BILL 1629 AND THE LONG-TERM CARE REIMBURSEMENT ACT: DID NURSING HOME NURSE STAFFING CHANGE?" VCU Scholars Compass, 2011. https://scholarscompass.vcu.edu/etd/2366.
Full textHopes, Scott L. "Healthcare IT in Skilled Nursing and Post-Acute Care Facilities: Reducing Hospital Admissions and Re-Admissions, Improving Reimbursement and Improving Clinical Operations." Scholar Commons, 2017. https://scholarcommons.usf.edu/etd/7409.
Full textStråle, Johansson Nathalie, and Malin Tjernström. "The Perfect Contract - Does it Exist? : A case study of Health Choice Västerbotten and its reimbursement system, focusing on the effects on motivation and competition." Thesis, Umeå universitet, Företagsekonomi, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-79154.
Full textLucas, D. Pulane. "Disruptive Transformations in Health Care: Technological Innovation and the Acute Care General Hospital." VCU Scholars Compass, 2013. http://scholarscompass.vcu.edu/etd/2996.
Full textSiazon, Maria Reina Ventura. "Evaluating the Discharge Process Improvement Initiative in Reducing the Length of Stay." ScholarWorks, 2019. https://scholarworks.waldenu.edu/dissertations/6949.
Full textBeneda, Tomáš. "Analýza systému zdravotnictví ve Spolkové republice Německo." Master's thesis, Vysoká škola ekonomická v Praze, 2008. http://www.nusl.cz/ntk/nusl-9621.
Full textKerns, Elizabeth E. "A Study on the Efficacy of the Medicare Bundled Payments for Care Improvement Initiative at a Large Community Hospital in the Southeast United States." Scholar Commons, 2017. http://scholarcommons.usf.edu/etd/7044.
Full textNarasimhan, Anirudhan. "Commercialization of HFAC Electronic Nerve Block Technology to Treat Chronic Post Surgical Pain." Case Western Reserve University School of Graduate Studies / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=case1290641992.
Full textRodriguez, Jason. "Reimbursement comes from the heart the organizational structure of emotions and care-work in nursing homes /." Amherst, Mass. : University of Massachusetts Amherst, 2009. http://scholarworks.umass.edu/dissertations/AAI3380010/.
Full textChen, Pei-Chen, and 陳珮甄. "The Impacts of the National Health Insurance Reimbursement Price on the Utilization of Oral Hypoglycemic Agents for Ambulatory Care." Thesis, 2006. http://ndltd.ncl.edu.tw/handle/66938859762383893330.
Full text國立成功大學
臨床藥學研究所
94
Background Changes in drug expenditure can be divided into 3 components: the prices of drugs, the quantity of drugs consumed and a residual. The size of the residual is a measure of the effect of changes in drug treatment patterns on drug expenditure. Recent empirical studies suggested that the health-care organizations consider “whether National Health Insurance reimburses or not”, “the profit margin from pharmaceutical reimbursement”, and “price comparison” as the priority in pharmaceutical purchasing. No matter what accreditation level would be, health-care organizations tended to select the medicine with higher price. The prevalence and incidence of diabetes mellitus are all increasing which thus pose significant burden on the health care system. The proportion of medical expenditure for diabetes mellitus to total medical expenditure was high, especially among the ambulatory care. And the mean medical expenditure for one diabetes mellitus patient was higher than that for non-diabetes mellitus. To control diabetes mellitus, most patients were treated with oral hypoglycemic agents (OHAs). Therefore, the prescribing patterns of OHAs were selected as the study subject. Objective To estimate the relationship between reimbursement price and prescribing patterns of brand and generic OHAs under the pharmaceutical reimbursement scheme of National Health Insurance. Methods The health care claim data from the National Health Insurance (NHI) program during the period 1997-2004 was included for analysis. Microsoft Excel and SAS package software were used for data analysis. And, the relationship among the independent variable, controlled variables and the dependent variable was examined by descriptive analysis and inferential statistics. Results The patient number and frequency for medical consultations of diabetes mellitus were increasing during the study period. Nearly, all the diabetic patients were treated with hypoglycemic agents: 13% of those patients took insulin, and 96% patients took OHAs. In medical centers, metropolitan hospitals, and local community hospitals, the proportion of brand pharmaceuticals prescription frequency to total OHAs and the proportion of brand pharmaceuticals consumption to total OHAs were higher than those of generic pharmaceuticals. Drug utilization in primary clinics was mainly generic pharmaceuticals. The results of multivariance regression analysis showed that health-care organizations tended to use generic pharmaceuticals when NHI reimbursement price had been decreased. The lower the reimbursement price, the more quantity the health-care organizations had consumed. Public hospitals, medical centers, and metropolitan hospitals tended to use more brand pharmaceuticals, while primary clinics did not. After implementing the Global Budget, health-care organizations did not tend to prescribe brand-name pharmaceuticals, and the quantity per day per patient all increased in medical centers, metropolitan hospitals, and local community hospitals, but it decreased in primary clinics. Conclusion First, there was difference in the OHAs utilization between brand- and generic pharmaceuticals. In medical centers, metropolitan hospitals, and local community hospitals, the proportion of brand pharmaceuticals prescription frequency and consumption to total OHAs were higher than generic pharmaceuticals. Drug utilization in primary clinics was mainly generic pharmaceuticals. No matter what accreditation level of health-care organizations would be, quantity per day per patient of brand pharmaceuticals was higher than generic pharmaceuticals. Secondly, NHI reimbursement price indeed affected drug utilization of oral hypoglycemic agents. When NHI reimbursement price had been decreased, health-care organizations tended to use more generic pharmaceuticals. The lower the reimbursement price, the more quantity the health-care organizations had consumed.
Shyu, Horng-Jeng, and 徐弘正. "The Impacts of Physicians' Behavior Affected by the Optimal Health Care Resources Allocation Under the Global Budget Reimbursement System." Thesis, 2013. http://ndltd.ncl.edu.tw/handle/87630851467654774476.
Full text亞洲大學
健康產業管理學系健康管理組
102
After the launch of Taiwan's National Health Insurance (NHI), the fee-for-service (FFS) payment system allowed hospitals to provide accessible health care. However, continually rising healthcare costs resulted in an unsustainable burden on the system. The global budget payment system (GBPS) has been implemented, which not only controlled health care costs but also motivated the hospital to enhance management efficacy. Determining how to appropriately allocate limited hospital claims resources among its physicians became an important management issue. Without proper allocation of physicians' claims resources, It could induce the unethical behaviors, such as unnecessary drug prescriptions leading to drug costs increasing and medical resources abuse. Thus, appropriate allocation of claims resources is essential to hospital revenue management. It also allows physicians to service a greater number of patients, while limiting the unnecessary waste of resources. This study analyzed the issue of claims resources allocation under the consideration of patient needs and medical services supply of physicians. This study employed the genetic algorithms (GA)and Monte Carol simulation to tackle the uncertainty of patient volumes in the optimization process. The objects of this study was to find out the impacts of physicians' behavior affected by the optimal healthcare resources allocation under the global budget reimbursement system. The study results of outpatient data revealed that physicians of over-budget group had character of well-trained background from center clinic. Their patient's profile had more severity nature with higher CMI. The physicians of below-budget group failed to meet budget in the spring season but better to meet budget in the winter season. The study results of inpatient data revealed over-budget physicians had higher CMI patients and higher service price of their prescription. The physicians' budget compliance of post allocation strategy revealed significant difference in seasons and physician's training background and patient's CMI nature by GEE statistic method. These conclusions could be suggested as a foundation of pre-implement planning of resources allocation strategy of hospital management. Hospitals could use historical data on claims' data as a basis for optimization, and utilize the existing health information system (HIS) as an self-regulation platform for managing budget by physicians.
Brown-Podgorski, Brittany L. "Examining the Impact of State-Mandated Insurance Benefits and Reimbursement Provisions on Access to Diabetes Self-Management Education and Training (DSME/T)." Diss., 2019. http://hdl.handle.net/1805/21085.
Full textWith an estimated 30.2 million diagnosed and undiagnosed cases among adults (and another 84 million at risk), diabetes mellitus is one of the most prevalent chronic conditions and a leading cause of mortality in the US. Diabetes self-management education and training (DSME/T) is a recognized standard of care and provides patients with the requisite knowledge and skills to properly manage the condition, improve long-term health outcomes, and reduce health care expenditures. Yet, DSME/T is greatly underutilized. Health insurance coverage that does not include benefits for DSME/T effectively imposes barriers to access for patients in need of the service. Many states have adopted laws and regulations requiring public and/or private insurers in their market to provide benefits for DSME/T; however, these requirements vary by state. It is unclear if these policies effectively improve access to DSME/T services. This dissertation seeks to rigorously assess the impact of state-mandated benefits and reimbursement provisions on access to DSME/T among adult patients with diabetes. The first analysis utilizes a unique combination of legal and programmatic data to quantify changes in the supply of DSME/T resources after the adoption of state-mandated benefits (potential access). The second analysis merges legal data with the Medical Expenditure Panel Survey (MEPS) from 2008 to 2016 to examine the impact of state mandates and reimbursement provisions on patient utilization of DSME/T (realized access). Lastly, the final analysis utilizes electronic health record data (2010-2016) from a safety net population to determine if patients’ evaluated need for DSME/T predicts the likelihood of receiving a DSME/T referral during a provider encounter (equitable access). Using novel data sources and a sophisticated policy analysis technique, this study provides a rigorous assessment of the impact of decades of state policies designed to improve access to care.
2020-04-02
Chih-Lin and 陳志麟. "The Influence of NHI Drug Reimbursement Adjustment for Drug Utilization and Expenditure on Different Levels of Health Care Organizations from 2000 to 2002." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/26523577152011762096.
Full text中山醫學大學
醫學研究所
93
Background: National Health Insurance (NHI) Program has been launching for more than a decade, in which the drug expenditure has always been a large financial burden to Bureau of National Health Insurance (BNHI), from 62.1 billion in 1996 up to 80.4 billion in 1999. The growth rates at 1998 and 1999 even reached to 12.9% and 11.3% respectively. In view of the drastic increase in drug expenditure and its growth rate, BNHI in 1999 announced a drug reimbursement adjustment policy for drug utilization and expenditure aiming at controlling the drug expenditure to a reasonable level. Eventually, the expenditure on drug utilization has been decreasing from around 7% in 2000 to 3.1% in 2001, and then to 2.2% in 2002. Although the drug expenditure has been dropped to below 3%, the underlying factors controlling the growth are still unknown. The influence of the reimbursement adjustment policy on different levels of health care organizations has yet been studied. Therefore, the primary objective of this thesis is to analyze in-depth the utilization and expenditure of drug in between January 2000 to December 2002, three years of time when the new policy has been launched. Then, recommendations are inferred from the findings to improve the monitoring of the drug expenditure and medical care. Materials and methods: Data being analyzed is obtained from the BNHI, starting from January 2000 to December 2002. The data is basically the detail break-down expenditures the health organization units submitted to BNHI for reimbursement. In which, the data not only provides the information about the total amount of drug expenditure within the organization, but also provide detail information regarding the expenditures in different period of time, different levels and different departments, such as in-patient departments (IPD) and out-patient departments (OPD). Not all kinds of drug are studied in the thesis. Only the top 1000 drugs out of about 4000 drugs ranked by their total expenditures within the period of study will be selected, which have already constituted over 70% of the total amount on drug expenditure. Their trends are thus analyzed by using one-way ANOVA in different dimensions including by different levels, by AHFS and by in/out-patient departments. Results: Within the period of study, it is found that (1) the expenditures of all 19 categories of drugs in accordance with AHFS categorization are increasing. The expenditure in curing heart blood vessel is the largest. (2) By analysis the expenditure in different levels, it is also found that the drug expenditure in curing blood vessel is the largest in all 4 levels. (3) By different levels of health care organizations, the drug expenditure in curing heart blood vessel is the top in medical centers & regional hospitals while the drug expenditure in curing intestine is the top in district hospitals & clinics. Conclusions: (1) The drop of the expenditure in Vitamin should be due to the imposing of the reimbursement adjustment policy. (2) Observe a large amount of expenditure in anti-infection medicine in medical center, regional & district hospitals, it seems that infection has been an inevitable problem in hospital. A better monitoring system for infection control seems to be a topic to be concerned. (3) It is an alarm to our citizen that the expenditure of drugs for curing blood vessel is increasing. It seems necessary to have a campaign to promote the health care on heart diseases. (4) The proportional of the unclassified drugs is persistently in high level. Re-categorization should be done in the future.
Anita, Pei-Yi Huang, and 黃珮怡. "The Impact of National Health Insurance Reimbursement Policies on Business Strategy and Market Shaping Plan of Health Care IndustryCase Study for “A” product of “A” Medical Technology Company." Thesis, 2019. http://ndltd.ncl.edu.tw/handle/9bwvu8.
Full text國立臺灣大學
企業管理碩士專班
107
Abstract In Taiwan, everyone has health insurance and the coverage rate of national health insurance has already exceeded 99%; the health care benefits are also broadly covered and reimbursed, almost all-encompassing. As a result of the high insurance rate and high disease coverage rate, the National Health Insurance Administration (NHIA), Ministry of Health and Welfare has become the largest payer for the health care industry in Taiwan. Therefore, the reform of the national health insurance policy has significant impact on the operation and development of the entire health care industry. The financial status of national health insurance has always been a key focus of the public. Since being founded in 1995, with the ultimate goal of achieving a balance of payments, National Health Insurance Administration (NHIA) carried out a number of policy changes, such as global budget payment system, comprehensive drug price surveys, hospital self-management, Fee-for-service, and second-generation national health insurance, which was implemented in 2013. These changes in reimbursement policies are mainly to reduce or control expenditures, in order to achieve the goal of sustainable health care for all. The national health insurance policy, which control expenditures, hinders market growth, operation and development of the health care industry and even patient safety. The case study uses literature and company confidential data analysis to explore the impact of changes under national health insurance policy on Taiwan''s health care industry. It also uses “Case Study Method” to explore the impact of the case company under a critical environment and how it faces challenges and comes out with an effective strategy. The case study concluded that changes with national health insurance policy caused the case company product to vanish from the health care market and affected company operational performance. The case company leveraged health care professionals to re-enter the market successfully and resulting of the product being fully reimbursed by NHI instead of being a self-pay product before 2012. The transformation of this business model has allowed the case company product to continue growing, getting rid of the competition and shaping the market.
HUANG, YEU-JIUN, and 黃宇君. "Evaluation of the benefit of the Health care reimbursement for the new generation of NSAIDs(COX-2 selective NSAIDs) via retrospective analysis using data warehouse of BNHI Taiwan." Thesis, 2007. http://ndltd.ncl.edu.tw/handle/24730536060056057305.
Full text長庚大學
醫務管理學研究所
95
A new-generation non-steroid anti-inflammatory agent, known as COX-2, was introduced in 1998. This agent, according to clinical studies, produces a lower level of gastrointestinal toxicity than most conventional therapies and has soon become a popular treatment in medical practices. While the uses of COX-2 continue to grow, the rising expenses also draw the attention of health-care organizations concerning the effectiveness of such agent. In this study, an analysis on the effectiveness of COX-2 was performed based on medical claims submitted to the Bureau of National Health Insurance during 2004 and 2005 using the Logistic regression model. Comparisons were made on age, gender, medical facilities chosen, and ratio of inpatient anti-inflammatory treatment resulting from both conventional and COX-2 therapies. During the analysis, it was found that the average age of COX-2 users was higher than that of the others due to the age restriction in the insurance policy. Therefore, in order to avoid the estimation problem caused by this patient selection bias, a separate analysis was conducted on qualified patients alone. The results of this analysis indicate that for general patients, COX-2 users has a higher inpatient ratio (1.5%) than the recipients of traditional therapy (0.4%). For patients qualified for reimbursement, however, the inpatient ratio of COX-2 users (1.7%) is slightly lower than the other (1.9%), and the difference between these two becomes even less significant in the Logistic regression model.
Dobiáš, Michal. "Právní postavení nestátních zdravotnických zařízení v českém zdravotnictví." Master's thesis, 2011. http://www.nusl.cz/ntk/nusl-313068.
Full textBobula, Peter. "Vliv zájmových skupin na úhradovou vyhlášku zdravotnictví České republiky." Master's thesis, 2019. http://www.nusl.cz/ntk/nusl-406133.
Full textRodriquez, Jason. "Reimbursement comes from the heart: The organizational structure of emotions and care-work in nursing homes." 2009. https://scholarworks.umass.edu/dissertations/AAI3380010.
Full text